Fabry’s Disease: Global Pipeline Analysis 2018 – Covering 20 Drugs Currently in Different Phases of Development – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Fabry's Disease Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Developments" report has been added to ResearchAndMarkets.com's offering. The report provides Fabry's Disease treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing

Full Story →